The first Moderna trade was made in Q3 2021.
Since then Ray Dalio bought shares five more times and sold shares on seven occasions. The investor sold all their shares in Q1 2025 and doesn't own any shares in Moderna anymore.
Avg closing price
Price range
Sold -606 Thousand shares
Q1 2025
Avg closing price
$35.55
Price range
$28.35
-
$47.53
New holding (+606 Thousand shares)
Q4 2024
Avg closing price
$47.55
Price range
$36.85
-
$63.93
Sold -15.3 Thousand shares
Q3 2024
Avg closing price
$91.96
Price range
$63.64
-
$125.14
New holding (+15.3 Thousand shares)
Q2 2024
Avg closing price
$126.55
Price range
$101.21
-
$166.61
Sold -30.9 Thousand shares
Q3 2023
Avg closing price
$111.55
Price range
$96.41
-
$126.61
Increased shares by 474.1% (+25.5 Thousand shares)
Q2 2023
Avg closing price
$133.40
Price range
$118.50
-
$160.53
Sold 30.0% shares (-2.3 Thousand shares)
Q1 2023
Avg closing price
$164.97
Price range
$135.66
-
$197.02
Sold 56.0% shares (-9.76 Thousand shares)
Q4 2022
Avg closing price
$163.51
Price range
$118.38
-
$210.04
Sold 93.0% shares (-232 Thousand shares)
Q3 2022
Avg closing price
$151.74
Price range
$118.07
-
$194.18
Increased shares by 433.7% (+202 Thousand shares)
Q2 2022
Avg closing price
$142.94
Price range
$117.13
-
$176.59
Increased shares by 1182.8% (+43 Thousand shares)
Q1 2022